Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease

Molecules. 2016 Oct 11;21(10):1338. doi: 10.3390/molecules21101338.

Abstract

Five novel tacrine-ferulic acid hybrid compounds (8a-e) were synthesized and their structures were identified on the basis of a detailed spectroscopic analysis. The activities of inhibiting acetyl cholinesterase (AChE) and butyryl cholinesterase (BuChE), reducing self-induced β-amyloid (Aβ) aggregation and chelating Cu2+ were evaluated in vitro. Among them, 8c and 8d displayed the higher selectivity in inhibiting AChE over BuChE. Moreover, 8d also showed dramatic inhibition of self-Aβ aggregation, activity of chelating Cu2+ and activity against Aβ-induced neurotoxicity in Neuro-2A cells.

Keywords: cholinesterase; ferulic acid; metal chelator; neuroprotection; tacrine; β-amyloid aggregation.

MeSH terms

  • Acetylcholinesterase / metabolism
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / metabolism
  • Butyrylcholinesterase / metabolism
  • Cell Line
  • Cell Survival / drug effects
  • Chelating Agents / chemical synthesis*
  • Chelating Agents / chemistry
  • Chelating Agents / pharmacology
  • Cholinesterase Inhibitors / chemical synthesis*
  • Cholinesterase Inhibitors / chemistry
  • Cholinesterase Inhibitors / pharmacology*
  • Coumaric Acids / chemistry*
  • Coumaric Acids / pharmacology
  • Drug Design
  • Humans
  • Molecular Docking Simulation
  • Molecular Structure
  • Structure-Activity Relationship
  • Tacrine / chemistry*
  • Tacrine / pharmacology

Substances

  • Amyloid beta-Peptides
  • Chelating Agents
  • Cholinesterase Inhibitors
  • Coumaric Acids
  • Tacrine
  • ferulic acid
  • Acetylcholinesterase
  • Butyrylcholinesterase